Developing New Tools to Fight Human Pathogens: A Journey through the Advances in RNA Technologies

Vanessa G. Costa, Susana M. Costa, Margarida Saramago, Marta V. Cunha, Cecília M. Arraiano, Sandra C. Viegas, Rute G. Matos

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)

Abstract

A long scientific journey has led to prominent technological advances in the RNA field, and several new types of molecules have been discovered, from non-coding RNAs (ncRNAs) to riboswitches, small interfering RNAs (siRNAs) and CRISPR systems. Such findings, together with the recognition of the advantages of RNA in terms of its functional performance, have attracted the attention of synthetic biologists to create potent RNA-based tools for biotechnological and medical applications. In this review, we have gathered the knowledge on the connection between RNA metabolism and pathogenesis in Gram-positive and Gram-negative bacteria. We further discuss how RNA techniques have contributed to the building of this knowledge and the development of new tools in synthetic biology for the diagnosis and treatment of diseases caused by pathogenic microorganisms. Infectious diseases are still a world-leading cause of death and morbidity, and RNA-based therapeutics have arisen as an alternative way to achieve success. There are still obstacles to overcome in its application, but much progress has been made in a fast and effective manner, paving the way for the solid establishment of RNA-based therapies in the future.

Original languageEnglish
Article number2303
JournalMicroorganisms
Volume10
Issue number11
DOIs
Publication statusPublished - Nov 2022

Keywords

  • CRISPR
  • ribonucleases
  • RNA chaperones
  • RNA metabolism
  • RNA regulators
  • RNA tool
  • small non-coding RNAs (ncRNAs)
  • synthetic biology
  • virulence

Fingerprint

Dive into the research topics of 'Developing New Tools to Fight Human Pathogens: A Journey through the Advances in RNA Technologies'. Together they form a unique fingerprint.

Cite this